Results 41 to 50 of about 8,380,026 (270)
Experience with sonidegib in patients with advanced basal cell carcinoma: case reports
Drugs in Context, 2022 Sonidegib is a Hedgehog signalling pathway inhibitor approved for use in patients with advanced basal cell carcinoma (BCC) not eligible for surgery or radiotherapy.
Susana Puig +4 more
doaj +1 more source
Treatment of periocular basal cell carcinoma with neoadjuvant vismodegib
American Journal of Ophthalmology Case Reports, 2020 Purpose: To report a case of a locally advanced periocular basal cell carcinoma treated with neoadjuvant Vismodegib therapy prior to surgery. Observations: A 63-year-old female presented to the oculoplastics clinic with biopsy-proven basal cell carcinoma
Maxwell G. Su +2 more
doaj +1 more source
Gefitinib and Radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck [PDF]
, 2008 Introduction: Gefitinib, an orally active epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces growth arrest in squamous cancer cell carcinoma of head and neck (SCCHN) cell lines mainly by blocking cells in G1 and preventing them ...
Romano, Carmela
core +1 more source
Skin Health and Disease, 2023 Nevoid basal cell carcinoma syndrome (NBCCS, Gorlin syndrome) is a rare genetic condition characterized by the early development of numerous cutaneous basal cell carcinomas (BCCs).
Federico Venturi +5 more
doaj +1 more source
The role of GLI2 in human basal cell carcinoma tumourigenesis [PDF]
, 2010 PhDAbnormal Sonic Hedgehog (SHH) signalling leads to increased transcriptional activation of its downstream effector, GLI2, which is implicated in the pathogenesis of a variety of human tumours, including human basal cell carcinoma (BCC).
Pantazi, Eleni
core +2 more sources
African Journal of Urology, 2021 Background Basal cell carcinoma of the prostate is a relatively rare entity. Their evolution is characterized by the frequency of local and/or distant relapses. Due to their rarity, the treatment is not consensual in the literature. We report here a case
S. Ridai +6 more
doaj +1 more source
Vismodegib for Locally Advanced Basal Cell Carcinoma in a Heart Transplant Patient [PDF]
JAMA Dermatology, 2015 Immunosuppressed patients with solid organ transplants have an increased risk for nonmelanoma skin cancer. Vismodegib has been reported to be effective for select locally advanced or metastatic basal cell carcinomas. However, there is no data documenting the use and safety of vismodegib in immunosuppressed organ transplant patients.We describe a 78 ...
Carrie Ann, Cusack +6 more
openaire +2 more sources
Brief overview: cemiplimab for the treatment of advanced basal cell carcinoma: PD-1 strikes again
Therapeutic Advances in Medical Oncology, 2022 Basal cell carcinoma (BCC) is the most common malignancy worldwide. Fortunately, most tumors are localized and easily amenable to surgical resection or locally destructive treatments.
Christina M. Davis, Karl D. Lewis
doaj +1 more source
, 2021 Lasting response after discontinuation of cemiplimab in a patient with locally advanced basal cell ...
Scarfi F. +13 more
core +1 more source
Periocular basal cell carcinoma with orbital invasion: a case report [PDF]
Surgical & Cosmetic DermatologyBasal cell carcinoma is the most frequent periocular neoplasm. Although mortality is low, orbital invasion represents a severe complication associated with high morbidity.
Mariana Sofia Monteiro Silva +4 more
doaj +1 more source